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The original concept of systemic lupus erythematosus was that of a rapidly 
progressive, often fulminant, fatal disease primarily affecting women in the 
reproductive age group. Subsequent observations, however, have revealed many 
additional and protean aspects of this disorder. 
The purpose of this report is to  call attention to the onset of the disease in one 
specific group in which it is not often suspected, namely, patients in the sixth 
decade of life or later (1-8). Although the age range for appearance of the disease 
is from 2 to 73 years, most of the cases (75-84 per cent) occur between the ages 
of 10 and 40 years, the average age at  onset being from 25 to 30 years. Despite 
the inclusion of patients aged 50 or over in statistical summaries of previously 
published series, there has been only 1 such patient reported in detail. Knopf 
and Castor (9) presented the case of a woman in whom, at  age 66, joint pains, 
pleural effusion and thrombocytopenia developed in association with diagnostic 
findings in a lupus erythematosus cell preparation. At the time of publication, the 
patient’s symptoms were controlled with minimal dosages of prednisone, aspirin 
and antimalarials. 
In the period 1950-1958,5 patients with systemic lupus erythematosus whose 
disease became manifest in the sixth decade of life or later, were studied in the 
Hematology Section of the Department of Medicine at  Temple University 
Medical Center. This incidence suggests a frequency of onset of systemic lupus 
erythematosus in the older population greater than generally recognized. Analy- 
sis of these cases permits certain preliminary observations on the nature of this 
variable disease in the elderly patient. 
CASE REPORTS 
Case 1 
W7. S., a 73-year-old male, was in his usual state of good health until December 1951, 
at which time he contracted an acute febrile illness, diagnosed as “flu” and treated with 
penicillin. He was also found to be anemic and was given a series of four weekly injections 
of liver extract. Following the fourth injection he became severely ill with loss of appetite, 
ankle swelling, enlargement of the cervical lymph nodes, swelling of the eyelids with 
purplish discoloration, abdominal pain, sciatica and iritis. His weight a t  that time was 
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recorded as 154 pounds, which represented a loss of approximately 16 pounds from his 
normal level. Admission to another hospital resulted in the discovery of neutropenia 
and thrombocytopenia in addition to anemia. Megaloblasts were seen in the sternal 
marrow aspirate and a diagnosis of pernicious anemia was considered. Accordingly vita- 
min B12 and folic acid were administered, but the hematologic abnormalities remained 
unchanged. In July 1952, cortisone therapy was started a t  the suggestion of an ophthal- 
mologic consultant, because of the persistence of iritis. Despite continued treatment 
with large doses of cortisone (up to 200 mg daily) and antibiotics, the patient remained 
ill for several months with intermittent fever ranging up to 103-104’F, joint swelling, 
and anemia. 
In March 1953, he was referred to one of us (C. Z.) for complete evaluation. In addi- 
tion to the foregoing, he displayed an extensive papular eruption over the arms, legs and 
back. Orthopnea was marked. His blood pressure was 160/85 mm Hg. Cardiomegaly 
was present, but there were no murmurs. The liver and spleen were not palpable. There 
was edema of the scrotum and of the lower extremities. The deep tendon reflexes were 
reactive and the deep pain sense was retained in the Achilles tendon. 
A Rumpel-Leede test gave moderately positive results. The hemoglobin level was 
8.9 gm per cent, the leukocyte count 2,500 per cu mm, erythrocyte count 2.78 million per 
cu mm, reticulocyte count 2.4 per cent, and thrombocyte count 528,000 per cu mm. The 
blood Wassermann test gave positive results (2 +), as did the Mazzini test (1 :8 dilution). 
The spinal fluid Wassermann results were also positive (4 +). However, the colloidal gold 
test reading on the spinal fluid was 0000000000. On further questioning it was determined 
that the patient’s blood Wassermann reaction had been positive for forty years and he had 
been adequately treated for lues despite the fact that there was no history of a primary 
lesion or known exposure. The Treponema pallidum immobilization test on several serum 
specimens yielded negative results. A lupus erythematosus cell preparation showed 9 
L.E. cells among the 500 white blood cells counted. The direct Coombs’ test showed no 
antibodies. The diagnosis was disseminated lupus erythematosus with false positive 
luetic serologic findings. 
Therapy was started with cortisone (50 mg daily) potassium para-aminobenzoate 
(Potaba, 12 gm daily) and acetylsalicylic acid. During the next few months the patient 
experienced several exacerbations of his illness with high fever, arthralgia, and an ery- 
thematous skin eruption. A temporary increase in cortisone dosage to 200 to 250 mg daily 
usually resulted in subsidence of the acute symptoms, but reduction in dosage was in- 
variably followed by recurrence. K aminobenzoate was continued during this entire period. 
By October 1953, approximately six months after institution of combined therapy, the 
patient was symptom-free. The total daily requirement of cortisone was only 50 mg, given 
in fractional doses. 
Subsequently the patient’s course was one of general good health with occasional flare- 
ups characterized by malaise, fever, skin eruption and ankle swelling. These episodes 
were short-lived and far between, with good response to short-term increases in corti- 
costeroid and salicylate dosages. At the age of 75 he was able to mow his lawn and walk 
several miles without undue fatigue. 
In May 1960, low back pain and constipation developed and grew progressively worse, 
necessitating admission to Temple University Hospital on May 31, 1960. The hemoglobin 
level was 11.7 gm per cent, hematocrit 37 per cent, and leukocyte count 3,600 per cu mm, 
with 57% segmented neutrophils, 27% lymphocytes, 4% monocytes and 6.5% disin- 
tegrated cells. The reticulocyte count was 2.1 per cent, thrombocyte count 390,000 per 
cu mm, and erythrocyte count 3.7 million per cu mm. A lupus erythematosus cell prep- 
aration showed no L. E. cells. The urine was normal. The concentration of blood urea 
nitrogen was 18 mg per 100 ml, serum calcium 9.2 mg per 100 ml, serum phosphorus 3.0 
mg per 100 ml, serum alkaline phosphatase 12.1 K.A. units, acid phosphatme 2.4 Units, 
and total bilirubin 0.57 mg per 100 ml. Roentgen examination of the lumbar spine re- 
vealed generalized osteoporosis and a mild compression fracture at  L2. Gastrointestinal 
x-ray examination (barium enema) showed nothing abnormal. 
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Strict bedrest was instituted, and therapy consisted of cortisone, Potaba, Empirin 
compound and supportive care. While the patient was in the hospital, substernal chest 
pain developed. An electrocardiogram showed right bundle-branch block, premature 
auricular contractions, diffuse myocardial abnormality, and an old diaphragmatic in- 
farct. The course was one of continued weakness and constipation with progressive dis- 
orientation. On July 3,1960, swelling of the left leg was first noted, but there was no heat, 
redness or tenderness. This swelling persisted until the patient’s death on July 12, 1960, 
a t  the age of 80 years. 
Necropsy revealed multiple, bilateral pulmonary emboli, bronchopneumonia and 
pulmonary edema. Examination of the pancreas showed primary adenocarcinoma with 
thrombosis of the pancreatic vein, cystic obstruction of the ducts and chronic pancreatitis. 
Metastases were present in the local lymph nodes. The kidneys showed moderate mem- 
branous glomerulosclerosis (lupus type) with mild focal pyelonephritis and arteriolo- 
sclerosis. There was thrombophlebitis in the vessels of the left leg. 
Comment: A striking feature of this case is the 40-year history of a positive 
reaction with serologic Wassermann or Mazzini tests. Repeated treponemal 
immobilization tests proved this positive serologic reaction to  be non-luetic. 
Such a false positive reaction in tests on the cerebrospinal fluid has not been re- 
ported previously. Also of interest is the apparent amelioration of the disease 
process during combined corticosteroid-K aminobenzoate therapy. During the 
first two years of clinically evident lupus erythematosus the patient was acutely 
ill a great deal of the  time and large doses of cortisone were required for subopti- 
mal control. With the addition of K aminobenzoate, prolonged symptom-free 
intervals over a 7-year period were achieved with lesser amounts of cortisone. 
Case 2 
S. P., a 58-year-old male, was first seen a t  Temple University Hospital in 1952, when 
he was admitted to the medical ward service with a history of pneumonitis accompanied 
by minimal pleural effusion and mild arthralgia. A lupus erythematosus cell preparation 
on July 21, 1953 showed 27 L. E. cells per 500 leukocytes examined. The patient’s symp- 
toms improved with corticosteroid therapy, and when he was discharged he was taking 
100 mg of cortisone daily. 
He was next seen on July 14,1954, when he was readmitted in a comatose, febrile state. 
The history obtained from the family disclosed that the patient had taken his usual dosage 
of medication until six days before admission, when the dosage had been increased to 
300 mg daily because of the sudden onset of fever and chills. Three days later left-sided 
hemiparesis developed and the patient gradually became more stuporous. On admission 
there was an obvious left central seventh-nerve palsy and weakness of the left arm and 
leg. Moist coarse rales were heard at  the left lung base. 
Laboratory studies: The hemoglobin level was 12.9 gm per cent, hematocrit 43.5 per 
cent, reticulocyte count 0.6 per cent, platelet count 872,000 per cu mm, and leukocyte 
count 8,500 per cu mm, with 7% band neutrophils, 84.5% segmented neutrophils, 4.5% 
lymphocytes, 3% monocytes and 1 % disintegrated cells. A lupus erythematosus cell 
preparation showed only 1 L. E. cell per 500 white cells counted. Repeated urinalyses 
gave negative results except for variable amounts of glycosuria. The fasting blood sugar 
level was moderately elevated. A chest roentgenogram showed diffuse exudative lesions 
compatible with acute pulmonary tuberculosis, and the sputum contained acid-fast 
bacilli. 
Treatment with streptomycin (I gram daily), potassium aminobenzoate (Potaba, 12 
grams daily), and intravenous adrenocorticotropic hormone (ACTH) WILS given in addi- 
tion to the corticosteroid therapy. The elevated level of blood sugar was readily controlled 
with small doses of NPH insulin. The patient’s cerebrovascular status improved and the 
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pulmonary lesions appeared to be responding to therapy. A cautious attempt was made 
to lower the corticosteroid dosage, and the last dose of ACTH was given on August 24. 
On August 25, 1954, the leukocyte count was 2,000 per cu mm, with no segmented neu- 
trophils. Examination of the sternal marrow aspirate revealed complete absence of seg- 
mented neutrophils and metamyelocytes, but more primitive forms (blasts, progranulo- 
cytes, myelocytes) were present in relative abundance. Erythropoiesis was normal. ACTH 
was re-started on August 27, 1954 and the leukocyte count rapidly returned to normal. 
ACTH was again gradually withdrawn, this time without difficulty, and the patient was 
transferred to Eagleville Sanatorium for treatment of tuberculosis on September 3, 1954. 
A lupus erythematosus cell preparation prior to discharge showed 5 L. E. cells per 100 
leukocytes. 
During the patient’s stay a t  Eagleville, treatment with streptomycin, isoniazid, K 
aminobenzoate and NPH insulin was continued. The insulin was withdrawn during his 
hospital stay, but the blood sugar level remained normal. The patient improved remark- 
ably and gained 46 pounds. Chest roentgenograms, which on admission to Eagleville 
showed extensive exudative changes involving the upper aspect of both lungs, now 
showed clearing of the exudative process with residual fibrosis. However, the sputum 
still contained acid-fast bacilli. The patient wished to continue his treatment at  home, 
and was discharged as improved on January 14, 1956. 
He returned to the special hematology clinic a t  Temple University Hospital on Janu- 
ary 26, 1956. At this time he felt well. The hemoglobin level was 13.5 gm per cent, hema- 
tocrit 43 per cent, and leukocyte count 6,300 per cu mm, with a normal differential dis- 
tribution. An L. E. cell preparation yielded negative results. Anti-tuberculosis medication 
and Potaba were continued on an ambulatory basis. The patient remained asymptomatic 
until January 30, 1958, when on a routine clinic visit he reported the painless passage of 
bright red blood in his urine. Following a visit to the urology clinic, he was admitted to the 
urology service on February 7, 1958, with symptoms of urinary frequency, urgency, 
dysuria and nocturia. Admission studies indicated the presence of urinary-tract infection 
due to coliform organisms, apparently on the basis of outlet obstruction. 
The hemoglobin level on admission was 13.7 gm per cent, and the leukocyte count 5,500 
per cu mm. The level of blood urea nitrogen was 7 mg, and total protein 7.8 gm per 100 
ml (albumin 4.7 gm, globulin 3.1 gm and an A/G ratio of 1.5). The level of fasting 
blood sugar was 100 mg per 100 ml. Serum calcium, phosphorus and alkaline phosphatase 
levels were normal. A chest roentgenogram showed some fibrosis and contracture in both 
upper lobes. The patient was given K aminobenzoate (Potaba), streptomycin and iso- 
niazid (Rimifon). 
On February 8, 1958, a cystoscopic examination revealed a large vesical calculus and 
trilobar prostatic hyperplasia. The patient was prepared for surgery by cortisone (150 
mg daily) and the calculus was removed suprapubically on February 12. The cortisone 
dosage was maintained postoperatively. The hemoglobin level on February 19 was 12.5 
gm per cent. One week after the initial procedure, the patient was again taken to the oper- 
ating room and a transurethral resection was performed (spinal anesthesia). Blood loss 
was minimal and the patient did well until the fourth postoperative day, when the urethral 
catheter was removed; that evening he suddenly experienced chills and a fever as high as 
105°F. This was attributed to bacteremia associated with removal of the catheter, although 
culture of a blood specimen taken at  the time subsequently yielded no growth. The patient 
was given chloramphenicol and appeared to be responding well; the fever subsided. The 
cortisone dosage was gradually reduced to 50 mg daily. On March 3, 1958, he complained 
of weakness and lightheadedness, and the blood tests were repeated. The hemoglobin level 
was 5.5 gm per cent, leukocyte count 10,500 per cu mm with a slight increase in segmented 
neutrophils, reticulocyte count 1.5 per cent, and thrombocyte count increased. L. E. cell 
preparations gave negative results. The patient was transfused with packed red blood 
cells, the cortisone dosage wm increased to 75 mg every eight hours, and tetracycline 
was started. Chloramphenicol was discontinued. A chest x-ray film on March 6, 1958 
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revealed prominence of the pulmonary vascular markings and a mottled haziness though- 
out both lungs. These findings were interpreted as representing either congestion, re- 
activation of the tuberculous process, or the pulmonary changes of lupus erythematosus. 
The patient was digitalized on March 6, and appeared to improve symptomatically. On 
March 7, the hemoglobin level was 10.5 gm per cent, and the reticulocyte count 5.6 per 
cent. The leukocyte count had risen to 28,200 per cu mm, with marked neutrophilia. On 
the evening of March 7, 1958, acute pulmonary edema developed and the patient died. 
Necropsy revealed stress ulcers of the gastrointestinal tract and bilateral hemorrhagic, 
necrotic tracheobronchitis and bronchopneumonia. Culture of these lung tissues demon- 
strated Staphylococcus aureus, coagulase-positive. 
Gross and microscopic observations failed to provide definite evidence of lupus ery- 
thematosus activity or of tuberculous infection. Some splenic arterioles showed periar- 
teriolar fibrosis and some of the renal glomeruli showed slight thickening of the basement 
membrane. Death a t  age 64 appeared due to overwhelming sepsis. 
Comment: Despite the coincidence of widespread tuberculosis and lupus 
erythematosus, this patient remained in good health for four years while being 
treated with K aminobenzoate (Potaba) and anti-tuberculosis drugs. The 
probable contribution of the  previous high dosage of corticosteroids to  the de- 
velopment of fulminant tuberculosis in this elderly patient cannot be overlooked. 
Case 3 
C .  F., a 65-year-old white male, was first seen at  Temple University Medical Center in 
October 1958. At that time he gave a history of pain, redness, swelling and stiffness in the 
small joints of his fingers, toes and feet; this had been present for the preceding four years. 
Nodules had been noted on his feet, fingers and both forearms. A diagnosis of rheumatoid 
arthritis had been made, and treatment with 5 mg of prednisone daily had been carried 
out for a four-year period. Pain relief had been only partial, however. Four months before 
his visit an eruption developed on the exposed areas of the body, arms, face and neck 
following exposure to sunlight. It consisted of uniform round, erythematous lesions ac- 
companied by intense itching. Early in August 1958 the patient was seen at the hospital 
of the National Institutes of Health. Extensive clinical and laboratory studies were made, 
including an L. E. cell preparation for which the findings were reported as positive. The 
patient was told that he had lupus erythematosus, and was given prednisone (Meticorten 
45 mg daily) for ten weeks. 
The past history, family history and system review were non-contributory. 
On physical examination the skin of the face, neck, and V-area of the chest was bright 
red, but no definite lesions were noted. Examination of the extremities revealed a pea- 
sized nodule on the dorsal surface of the right lower arm just below the elbow. Similar 
nodules were also palpable at  the bases of the second metatarsophalangeal joints bilater- 
ally. There were no other objective findings in the joints. 
On October 29,1958, the hemoglobin level was 17.1 gm per cent, hematocrit 50 per cent, 
and leukocyte count 6,400 per cu mm. The level of serum total protein was 6.9 gm per 
cent (albumin 4.6 gm and globulin2.3 gm). AnL. E. cell preparationand a cephalinfloccu- 
lation test gave negative results. The urine was normal. 
The patient was given K aminobenzoate (Potaba, 12 gm daily) and prednisone (5 mg 
four times daily). He did well on this regimen, and prednisone had been gradually reduced 
to 10 mg daily by January 26, 1959. During this time he remained well except for occa- 
sional mild joint stiffness. On February 23, L. E. cells were found in the L. E. preparation. 
On April 9, 1959, the patient experienced right upper quadrant abdominal pain unre- 
lieved by food, and was admitted to Temple University Medical Center because of pos- 
sible peptic ulcer. The admission physical examination revealed only right upper quadrant 
tenderness. Pertinent laboratory findings were : hemoglobin level 14.6 gm per cent, eryth- 
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rocyte count 4,500,000 per cu mm, hematocrit 46 per cent, leukocyte count 6,900 per cu 
mm with a normal differential distribution, and platelet count 472,000 per cu mm. An 
L. E. cell preparation gave negative results. The urine specific gravity was 1.007, but no 
other urinary abnormalities were found. The level (per 100 ml) of blood sugar was 110 
mg, blood urea nitrogen 10 mg and total serum protein 5.8 gm (albumin 4.6 gm, globulin 
1.2 gm, and A/G ratio 3.8). Results of a cephalin flocculation test were negative. The latex 
fixation test for rheumatoid arthritis showed a reaction. A gastrointestinal x-ray series 
revealed a sliding hiatal hernia. An intravenous urogram demonstrated a soft-tissue mass 
in the right upper quadrant near the lower pole of the right kidney; it measured about 10 
cm in diameter. 
Exploratory laparotomy was performed on April 30, 1959, and a benign renal cyst (8 
x 8 cm) was excised. The postoperative course was smooth and the patient was discharged 
on May 9, 1959. His treatment regimen was an ulcer diet, antispasmodics, antacids, and 
hydrocortisone (10 mg every eight hours). Following discharge he remained well until 
July 1960, when there was sudden loss of peripheral vision in the right eye. On examina- 
tion, a tumor of the retina was discovered, and enucleation was performed shortly there- 
after a t  Wills Eye Hospital. The histologic diagnosis was malignant melanoma. 
During the past year the patient has been symptom-free except for occasional stiffness 
of his muscles and joints. Repeated lupus erythematosus cell preparations have contained 
1 or 2 L. E. cells per 500 leukocytes counted. At present, therapy consists of 5 mg daily 
of prednisone, and 12 gm daily of K aminobenzoate. The patient is now aged 71. 
Comment: Case 3 also demonstrates the difficulty in attempting to  categorize 
every case of diffuse collagen disease as a single entity. This patient originally 
exhibited the typical changes of rheumatoid arthritis (involvement of the small 
joints of the  hands and feet, subcutaneous nodules, and positive results with the 
latex fixation test). Later in his course, a recurrent erythematous eruption and 
repeatedly positive findings with L. E. cell preparations warranted a n  additional 
diagnosis of lupus erythematosus. Since institution of treatment with K amino- 
benzoate, the patient has been free of troublesome symptoms while taking only 
5 mg daily of prednisone. 
Case 4 
G. W . ,  a 58-year-old male was first admitted to Temple University Hospital on July 
16, 1950, with the chief complaint of weakness of two years’ duration. In January 1949 he 
had been studied at  another Philadelphia hospital where anemia was observed; treatment 
with iron, liver, cobalt and B12 resulted in little improvement. On April 16, 1950, he was 
suddenly seized with epigastric pain and was re-admitted to the same hospital where an 
exploratory laparotomy revealed a distended gall bladder with stones. Cholecystectomy 
was performed, at  which time a normal sized spleen was observed. He was given 6 units 
of blood. At the time of discharge the diagnosis was “hemolytic anemia.” 
On admission to Temple University Hospital, the patient was fairly well nourished but 
rather pale. The sclerae were icteric. Abdominal examination revealed the scar of the 
previous cholecystectomy. The liver was palpable two fingerbreadths below the costal 
margin in the midclavicular line, and was tender and smooth. The spleen was not palpable. 
There were typical psoriatic lesions on the buttocks and left knee. 
Laboratory findings were as follows: cephalin flocculation, 3 +; serum bilirubin (in- 
direct) 1.2 mg per 100 ml, serum sodium 150 mEq per liter, serum potassium 4.85 mEq 
per liter and serum chlorides 378 mg per 100 ml. The blood urea nitrogen level was 16 
mg per 100 ml. The erythrocyte count was 2,200,000 per cu mm, hemoglobin level 7.2 
gm per cent, hematocrit 21 per cent, reticulocyte count 36 per cent, and leukocyte count 
4,400 per cu mm, with 67% neutrophds, 26% lymphocytes, 3% monocytes and 4% eosin- 
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ophils. An osmotic fragility test revealed increased hemolysis in hypotonic saline solutions. 
Gastric analysis showed mild hyperacidity. The sternal bone marrow aspirate showed 
marked normoblastic hyperplasia. 
A ten-day course of ACTH had no effect, and the patient refused splenectomy. He was 
discharged on August 9, 1950, to be followed in the Medical Clinic, which he visited 
sporadically. His complaints were chronic fatigue, moderate shortness of breath on exer- 
tion, a cough productive of small amounts of phlegm, and occasional bright red blood 
with bowel movements. Sigmoidoscopy was performed and internal and external hemor- 
rhoids were found. Several chest roentgenograms demonstrated pulmonary fibrosis and 
emphysema. The liver was palpable two to three fingerbreadths below the costal margin 
in the midclavicular line, but the spleen was not palpable. 
In  the period from October 1950 to April 1953, the hemoglobin level remained low, 
ranging from 7.2 gm to 12.0 gm per cent. The reticulocyte count ranged from 6.4 to 16 
per cent. The plasma was consistently icteric. Platelet counts and leukocyte counts were 
within normal limits. In November 1953 the findings in L. E. cell preparations, which 
previously had been negative, were positive and remained positive during the ensuing 
year; as many as 63 L. E. cells per 500 leukocytes were noted in these tests. Coombs’ 
tests gave negative results. 
In  May 1954, treatment was started with the following: K aminobenzoate (Potaba, 
12 gm per day), cortisone (12.5 mg every eight hours), testosterone Lingusorbs (2.5 mg 
per day), and a low-salt regimen. At the time therapy was started, he was complaining 
of right-sided pleuritic pain, increasing weakness, fatigue and arthralgia. These symptoms 
were unaccompanied by fever or other objective findings. The hemoglobin level was 12.2 
gm per cent, reticulocyte count 2.3 per cent, leukocyte count 6,900 per cu mm, and platelet 
count 700,000 per cu mm. Therapy was continued for about seven months, with moderate 
improvement of the subjective complaints. Lupus erythematosus preparations consistently 
contained L. E. cells. 
I n  January 1955, the patient discontinued treatment against advice. He consulted a 
non-medical practitioner, who prescribed various herb medications. In  November 1955 
he returned to clinic after an absence of ten months, with a complaint of pain and pro- 
gressive limitation of motion in the left shoulder, of two to three months’ duration. A 
roentgenogram of the left shoulder revealed a large destructive lesion involving the 
glenoid fossa of the left scapula. The patient was admitted to the orthopedic service on 
November 27, 1955, and a needle biopsy was performed under fluoroscopic guidance. No 
evidence of tumor was found. A skeletal survey showed no lytic lesions other than that in 
the left scapula. The level of total serum protein was 6.4 gm per cent (albumin 3.7 gm and 
globulin 2.7 gm). The urine was normal. The cells in a sternal marrow aspirate were nor- 
mal. Smears and cultures of the sputum and the aspirate from the shoulder lesion showed 
no acid-fast bacilli. During this admission, L. E. cell preparations gave negative results. 
The patient was discharged only to be re-admitted to the orthopedic service in January 
1956. At that time an open biopsy of the left scapular lesion was performed; the pathology 
report was adenocarcinoma, probably of a gastrointestinal origin. A chest roentgenogram 
revealed a destructive lesion of the right sixth rib in the mid-axillary line. A course of 
local x-ray irradiation (2000 r) was administered to the shoulder, and he was discharged. 
The patient continued to have marked pain and limitation of motion in the shoulder and 
was re-admitted in August 1956. The hemoglobin level was 10.2 gm per cent, erythrocyte 
count 3.5 million per cu mm, hematocrit 32.5 per cent, and leukocyte count 6,500 per cu 
mm, with normal differential distribution. An L. E. cell preparation gave negative results. 
The serum levels of acid and alkaline phosphatase and total protein (including A/G ratio) 
were normal. The urine was normal. The feces contained no occult blood. An intravenous 
urogram, a gastrointestinal roentgen examination (including barium enema) and bron- 
choscopy revealed nothing abnormal. 
In  the absence of a detectable primary lesion, a course of nitrogen mustard therapy 
was instituted. A dose of 6 mg was given on alternate days until a total dose of 24.0 mg 
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was reached. In addition, cortisone (12.5 mg every eight hours), methyltestosterone sub- 
lingually (2.5 mg daily), and potassium citrate (1.0 gm three times daily) were adminis- 
tered. This therapy provided little relief and the patient's physical condition continued to  
deteriorate. He died at home in January 1957. No autopsy was performed. 
Comment: This case illustrates the necessity of considering lupus erythemato- 
sus as the underlying disease in all cases of acquired hemolytic anemia, regardless 
of age at  onset. 
Case 5 
B. P., a 74-year-old woman, was first admitted to the hospital on September 26, 1954, 
with the chief complaint of arthritis of two months' duration. Involved were the meta- 
carpophalangeal joints, the proximal interphalangeal joints and the wrists. She gave a 
history of a rash on the bridge of her nose, first noted after exposure to sunlight. At the 
onset of her illness she had been given corticosteroids intravenously and this had afforded 
temporary relief. When a reduction in dosage was attempted, there was an increase in 
disability, a fever of 102 to 103"F, and involvement of additional joints. She was advised 
to enter the hospital for further evaluation. 
On physical examination there were raised, patchy lesions on the skin of the 
face (thought to resemble discoid lupus), and generalized adenopathy. Both hand grips 
were weak. There was minimal swelling of the metacarpophalangeal joints and proximal 
interphalangeal joints, and atrophy of the extensor muscles of the hand. 
Laboratory studies: hemoglobin level 12.4 gm per cent, leukocyte count 7,450 per cu 
mm with normal differential distribution, and thrombocyte count 271,000 per cu mm. 
The serologic test for syphilis gave negative results. Urine specific gravity was 1.010; 
1 + protein mas present and there were 10-12 leukocytes and 18-20 erythrocytes per high- 
power field. The level of total serum protein was 6.6 gm per cent (albumin 3.5 gm and 
globulin 3.1 gm). The blood urea nitrogen level was 11 mg per 100 ml. Blood and urine 
cultures showed no growths. On October 4, 1954, a lupus erythematosus cell preparation 
contained L. E. cells. A chest x-ray film and an electrocardiogram were within normal 
limits. Six days following admission the leukocyte count had fallen to 3,000 per cu mm. 
The patient was seen in consultation by one of us (C.  Z.), who confirmed the diagnosis 
of systemic lupus erythematosus. Treatment included a low-salt diet, cortisone (50 mg 
every six hours), K aminobenzoate (Potaba, 12 gm daily), and ascorbic acid (50 mg daily). 
Within three days her temperature became normal and she improved clinically. She was 
discharged on the thirty-fifth hospital day and told to take cortisone (50 mg every eight 
hours) and Potaba (12 gm per day). 
The patient did very well during the next two years, being maintained with prednisone 
(5 mg twice daily) and Potaba (12 gm daily). Her urine showed no evidence of cellular 
exudation, and joint symptoms were minimal. She regained the 18 pounds in weight which 
had been lost during her acute illness. 
Her second hospital stay was in November 1956, when she was admitted for pain in 
the lumbar region, aggravated by movement and relieved by lying flat in bed. Laboratory 
findings: hemoglobin level 12.0 gm per cent, erythrocyte count 3.7 million per cu mm, 
leukocyte count 6,600 per cu mm with normal differential distribution, and thrombocyte 
count 422,620 per cu mm. The level of blood urea nitrogen was 18 mg per 100 ml, serum 
phosphorus 4.0 mg per 100 ml, and alkaline phosphatase 2.5 units per 100 ml. Roentgeno- 
grams of the lumbar spine revealed osteoporosis and a compression fracture of L-1. She 
was fitted with a back brace and discharged. Her medication was prednisone (5 mg twice 
daily), norethandrolone (10 mg four times daily) and stilbestrol (5 mg daily for three 
weeks out of four). The back pain improved markedly with this program and she remained 
well. 
A year later she entered the hospital for re-evaluation. Roentgen examination showed 
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no further progression of the compression fracture of the spine. An abdominal mass was 
palpated which on pelvic examination was thought to be an ovarian cyst, perhaps stimu- 
lated by estrogen administration. The stilbestrol therefore was discontinued but the rest 
of the regimen was maintained. Again she did well. 
In January 1960, she was admitted to the hospital for the fourth and final time. She 
complained of severe abdominal pain and constipation of three days’ duration. On exami- 
nation, signs of hypercortisonism were evident, i.e., swelling of the soft tissues of the neck 
and face and truncal obesity. There was abdominal distention with hyperactive peristal- 
sis, generalized tenderness and rebound phenomena. A mass was now palpated in the 
lower left quadrant, but the previously mentioned right-sided mass was no longer felt. 
Leukocytes numbered 22,600 per cu mm, with 67% segmented neutrophils, 15% non- 
segmented forms, 15% lymphocytes and 3% monocytes. The hemoglobin level was 16.1 
gm per cent. The cephalin flocculation test gave negative results. The serum total pro- 
tein level was 6.7 gm per cent, with 3.9 gm of albumin. 
At laparotomy a perforated sigmoid diverticulum with generalized peritonitis was 
found. A colostomy was established in the transverse colon. Culture of the peritoneal 
exudate revealed coliform and proteus organisms. Before, during, and after surgery she 
was given chloramphenicol. She did well for seven days, but on the eighth postoperative 
day her temperature rose to 103°F. Blood cultures showed Gram-negative organisms. 
Massive doses of antibiotics and corticosteroids failed to reverse a rapidly down-hill 
course, and she died on January 31, 1960. 
Postmortem examination: There was a seropurulent exudate in the abdominal cavity. 
A large abscess in the sigmoid area communicated with a perforated diverticulum. The 
adrenals were small and atrophic. The blood vessels of the kidney showed glomerular 
thickening. There were scattered areas of thickening of the basement membrane with a fi- 
brinoid appearance. These changes were considered compatible with lupus erythematosus. 
Comment: This case, in contrast to the others reported here, is quite “typical” 
of the picture presented by lupus erythematosus in the younger age group-a 
butterfly rash and arthralgias in a woman. 
DISCUSSION 
Analysis of our cases together with a review of the pertinent literature sug- 
gests that the pattern of systemic lupus erythematosus as seen in the older 
population may differ significantly from that seen in most younger persons. Per- 
haps the most striking observation is the preponderance of males in our group 
(4 out of 5). This represents a reversal of the usual sex incidence for this disease. 
Typical series include those of Larson (4) (200 patients, of whom 9 were males) 
McCombs and Patterson (7) (77 patients, of whom 8 were males) and Rupe 
and Nickel (5) (100 patients, of whom 34 were males). In only one study other 
than ours was a majority of males noted. Svanborg and Solve11 (10) in Sweden 
reported a total of 24 patients, of whom 18 were males. 
When the age a t  onset is considered in relation to sex, the statistics are as 
follows. McCombs and Patterson had 8 patients who manifested signs of systemic 
lupus erythematosus at  age 50 or over; all of these were women. In Rupe and 
Nickel’s series, there were 10 patients with onset a t  age 50-59; of these, 5 were 
males and 5 were females. In the 60-69 year group there were 5 females and 3 
males. The only patient in whom systemic lupus erythematosus developed after 
the age of 70 was a male. Svanborg and Solvell’s 24 patients (with the previously 
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mentioned male preponderance) included 8 who were first noted to have the dis- 
ease after age 53; all of these were men. In contrast, Harvey et al. (1) noted no 
difference in the age at onset between males and females. 
Although no conclusions can be drawn from these conflicting data (Table l), 
it appears that males constitute a somewhat larger percentage of the patients 
who first manifest lupus erythematosus after the age of 50. 
The relationship of the virulence of the disease process to the age at onset has 
been discussed by McCombs and Patterson, in whose series the appearance of 
systemic lupus erythematosus after age 45 indicated a more favorable prognosis 
than when the onset was earlier in life. In a panel discussion published in “ln- 
flammation and Diseases of Connective Tissue” (Hahnemann Symposium) 
(11), Dubois also states that the disease is apparently more malignant in the 
younger patient and more benign in the older one. Of our 5 patients, 1 is alive 
and clinically well five years after the diagnosis of systemic lupus erythematosus 
was established; 2 died from carcinoma (one at  age 80 after seven years of com- 
fortable active life, and the other at  age 65, eight years after symptoms attribut- 
able to lupus were first noted); and 2 died of infections intimately related to 
surgical conditions, five and six years respectively after diagnosis of systemic 
lupus. It is of interest that all of our cases survived at least five years following 
definitive diagnosis, and that the 4 deaths were not directly related to the 
primary disease nor, apparently, to complications secondary to its treatment. 
The discovery of a malignant neoplasm either before death or at necropsy in 
3 of our 5 patients is noteworthy. In the 183 cases reviewed by Harvey ( I ) ,  ful- 
minating infection was the cause of death in all patients in whom manifestations 
of systemic lupus erythematosus were not believed to be directly responsible. 
There were no carcinomas reported in 91 deaths in Larson’s (4) series nor in the 
smaller groups of Jessar et al. (3), and McCombs and Patterson. Lansbury (12) 
reported 6 cases of collagen disease complicating malignant disease. In 2 of these 
patients-one a 36-year-old man with a seminoma, and the other a 57-year old 
man with squamous-cell carcinoma of the epiglottis and larynx-articular dis- 
turbances developed, in association with L. E. cells in lupus erythematosus cell 
TABLE 1 
Data from the Literature re Age at Onset i n  Relation to Sex 
“ ~ ~ ~ ~ ~ $  Rupe & Nickel Svanborg & Solve11 
Total number of cases . .  . . . . . . . . . . . . . . . . . .  77 100 24 
Total number of males. . . . . . . . . . . . . . . . . . .  8 34 18 
Number with onset after age 50: 
Males. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0 9 8 
Females. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  8 10 0 
age 50: 
Males. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0 23 44 
Females. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  19 12 0 
Percentage of total with onset after 
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preparations, within a year after the onset of the symptoms of malignancy. In our 
3 cases, the collagen disease was evident for several years before the discovery 
of the tumors. 
The paucity of previously published cases of co-existing malignant neoplasia 
and systemic lupus erytheniatosus is in direct contrast to the plethora of reports 
emphasizing the co-existence of a closely related collagen disease, dermatomyo- 
sitis, and visceral malignant neoplasia. Lansbury (12), Curtis et al. (13), Sheard 
(14), and Brunner and Lobraccio (15) all reported 1 or more cases prior to 1954. 
At present, it is thought that from 10 to 20 per cent of patients with derniatomyo- 
sitis have, or will have, a malignant neoplasm. 
Scleroderma, a third member of the collagen-disease group, although not 
widely recognized as associated with an increased incidence of malignant dis- 
ease, has been reported as co-existing with pulmonary carcinoma by several ob- 
servers (16-18). Another case of pulmonary carcinoma complicating longstanding 
scleroderma has been followed personally by the authors, as has a case of carci- 
noma of the sigmoid colon developing in a patient with sclerodernia of many 
years’ duration. 
Although it is not possible to relate any causal significance to the occurrence 
of malignant disease in our small series, it seems warranted to advise that search 
for an occult tumor be made in any patient in whom the clinical onset of lupus 
erythematosus has occurred in the later years of life. 
The phenomenon of demonstrable protein abnormalities preceding the earliest 
symptoms of lupus erytheniatosus by many years is well documented. Harvey 
(19) studied 192 patients in whom biologic tests for syphilis gave false-positive 
results; in 14 of these, systemic lupus developed. Haserick and Long (20) re- 
viewed the courses of 5 patients whose false-positive serologic reactions for 
for syphilis antedated the appearance of clinical lupus erythematosus by one to 
seven years. Moore and Lutz (21) reported 9 cases of verified systemic lupus that 
developed in 104 female biologic false-positive reactors from five to fifteen years 
after the abnormal serologic findings were first obtained. In addition, 52 of their 
patients eventually exhibited bizarre illnesses having features consistent with a 
collagen disease, but without lupus erythematosus cells in the L. E. cell prepara- 
tions. In our Case 1, there was a 40-year history of positive reactions in the sero- 
logic tests for syphilis; these were proved to be biologic false-positive reactions, 
on the basis of repeatedly negative results with Treponema pallidum immobiliza- 
tion tests. Although elevated levels of spinal fluid protein have frequently been 
found in patients with neurologic manifestations of systemic lupus, a search of the 
literature has failed to disclose any reports previous to that in our Case 1 of a 
false-positive cerebrospinal fluid reaction for syphilis in a case of lupus ery- 
thematosus. 
In another patient (not reported here in detail) in whom the diagnosis of lupus 
was made at age 53, there was a history of “sun poisoning” and a rash suggestive 
of a butterfly eruption twenty-five years before the onset of intermittent fever 
and arthralgias associated with L. E. cells in lupus erythematosus cell prepara- 
tions. This woman also reported hypersensitivity reactions to penicillin and 
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transfusions during the period between the probable origin of her disease and the 
emergence of a typical clinical and laboratory pattern. This case and Case 1 con- 
tribute further evidence to support the existence of a ((lupus diathesis,” in which 
isolated clinical or laboratory signs, or both, of the disease may precede the full 
blown syndrome by many years. In our series (with the possible exception of 
Case 1) we could not determine at  what age some abnormality related to lupus 
may have first been detectable. One can only speculate that in cases of systemic 
lupus apparently arising late in life, the evolution of the disease has been slow, 
and that subclinical abnormalities have existed for long periods. Careful retro- 
spective studies of the past histories and laboratory records of elderly patients 
with lupus erythematosus, as well as follow-up evaluations of serologic false- 
positive reactors and other patients with the “lupus diathesis,” are indispensable 
for confirmation of this hypothesis. 
The use of both K aminobenzoate and corticosteroids in the long-term manage- 
ment of systemic lupus erythematosus deserves comment. K aminobenzoate 
(Potaba) was first used successfully in the treatment of chronic discoid lupus by 
one of us in the 1940’s (22, 23). Early trials in systemic lupus, however, showed 
that only occasional patients with the disseminated form of the disease would 
respond to this medication. Accordingly, K aminobenzoate was not suggested as 
a primary form of treatment for the systemic form of the disease. Later, however, 
it was determined that by the introduction of this compound (at least 12 gm 
daily) into the treatment program, the amount of corticosteroids required for 
suppression of the clinical manifestations of systemic lupus, as well as of other 
disorders, could be substantially reduced (24, 25). The desirability of minimizing 
long-term steroid dosage in all patients is well recognized. In  the elderly patient, 
already prone to demineralization, the lessened risk of this complication occur- 
ring if K aminobenzoate is added to therapy, is a particular advantage. The long- 
term use of K aminobenzoate in conjunction with small doses of corticosteroids 
resulted in prolonged, relatively symptom-free periods in 4 patients of this series. 
SUMMARY 
Five cases of systemic lupus erythematosus with apparent onset in the sixth 
decade of l i e  or later are presented. Striking features of this series included the 
predominance of males (4 out of 5), the co-existence or development of malignant 
tumors in 3 of the 5 cases, and the fact that none of the 4 deaths was the direct 
result of systemic lupus or apparent complications of its treatment, which con- 
sisted chiefly of potassium para-aminobenzoate and small doses of cortico- 
steroids. A unique finding was that in 1 case a positive reaction with the sero- 
logic test for syphilis on the cerebrospinal fluid proved to be a biologic 
false-positive reaction. 
In  elderly patients, systemic lupus erythematosus should be considered in the 
differential diagnosis when any clinical or laboratory phenomena are observed 
which would arouse suspicion of this disorder in younger patients. 
Acknowledgment 
The authors wish to  thank Dr. H. James Day for permission to  include Cases 3 and 5. 
August 1964 LUPUS ERYTHEMATOSUS IN THE ELDERLY 799 
REFERENCES 
1.  HARVEY, A. 31.; SHULMAN, L. E.; TUMULTY, P. A.; CONLEY, C. L., AND SCHOENRICH, 
E. H.: Systemic lupus erythematosus: review of the literature and clinical analysis of 
138 cases, Medicine 33: 291 (Dec.) 1954. 
2.  SHEARN, 11. A., AND PEROFSHY, B.: Disseminated lupus erythematosus: analysis of 34 
cases, Arch. Int.  Med. 90: 790 (Dec.) 1952. 
3. JESSAR, . A.;  LAMONT-HAVERS, . W., AND RAGAN, C.: Natural history of lupus ery- 
thematosus disseminatus, Ann. Int.  Med. 38: 717 (Apr.) 1953. 
4. LARSON, D. L.: Systemic Lupus Erythematosus. Boston, Mass., Little, Brown and 
Co., 1953. 
5. TALBOTT, N.  H., AND FERRANDIS, R. M.: Collagen Diseases. New York, Grune and 
Stratton, 1956. 
6.  RUPE, C. E., AND NICKEL, S. N.: New clinical concept of systemic lupus erythematosus: 
analysis of 100 cases, J .A .M.A.  171: 1055 (Oct. 24) 1959. 
7. IMcConiss, R. P., AND PATTERSON, J. F.: Factors influencing course and prognosis of 
systemic lupus erythematosus, New England J .  Med. 260: 1955 (June 11) 1959. 
8. HASERICB, J. R.: Modern concept of systemic lupus erythematosus: review of 126 cases, 
J .  Chronic Dis.  1: 317 (March) 1955. 
9.  KNOPF, R. F., AND CASTOR, C. W.: Systemic lupus erythematosus in an elderly patient: 
a case report, Univ. of Mich. Med. Bull. 25: 20 (Jan.) 1959. 
10. SVANBORG, A., AND SOLVELL, L. : Incidence of disseminated lupus erythematosus : 
follow-up studies indicating increased frequency, J . A  .M.A. 166: 1126 (Nov. 2) 1957. 
11. DUBOIS, E. L.: I n  Inflammation and Diseases of Connective Tissues, ed. by L. C. 
Mills and J. H. Moyer. Philadelphia and London, W. B. Saunders Co., 1961. 
12. LANSBURY, J.: Collagen disease complicating malignancy, Ann. Rheum. Dis .  12: 301 
(Dec.) 1953. 
13. CCRTIS, A. C.; BLAYLOCK, H. C., AND HARRELL, E. R.,  JR.: Malignant lesions asso- 
ciated with dermatomyositis, J .A .M.A.  160: 844 (Nov. 1) 1952. 
14. SHEARD, C., JR.: Dermatomyositis, Arch. Int.  Med. 88: 640 (Nov.) 1951. 
15. BRUNNER, M. J., AND LOBRACCIO, R. V., JR.: Dermatomyositis as an index of malig- 
nant neoplasm, Ann. Int.  Med. 34: 1269 (May) 1951. 
16. RICHARDS, R. L., AND MILNE, J. A.: Cancer of the lung in progressive systemic sclerosis, 
Thorax 13: 238 (Sept.) 1958. 
17. ZATUCHNI, J.; CAMPBELL, W. N., AND ZARAFONETIS, C. J. D.: Pulmonary fibrosis and 
terminal bronchiolar (alveolar cell) carcinoma in scleroderma, Cancer 6: 1147 (Nov.) 1953. 
18. JONSSON, S. %I., AND HOUSER, J. M.: Scleroderma (progressive systemic sclerosis) 
associated with cancer of the lung, New England J .  Med. 255: 413 (Aug. 30) 1956. 
19. HARVEY, A. At.: Auto-immune disease and the chronic biologic false-positive test for 
syphilis, J . A  M . A .  182: 5 (Nov. 3) 1962. 
20. HASERICK, J. R . ,  AND LONG, R.: Systemic lupus erythematosus preceded by false-posi- 
tive serological tests for syphilis: presentation of 5 cases, Ann. Int.  Med. 37: 559 (Sept.) 
1952. 
21. MOORE, J .  E., AND LUTZ, W. B.: The natural history of systemic lupus erythematosus: 
an approach to its study through chronic biologic false-positive reactors, J. Chronic 
Dis .  1: 297 (March) 1955. 
22. ZARAFONETIS, C. J. D.; GREKIN, R. H., AND CURTIS, A. C.: Further studies on the 
treatment of lupus erythematosus with sodium para-aminobenzoate, J .  Invest. Derm. 
11: 359 (Nov.) 1948. 
23. ZARAFONETIS, C. J. D.: Therapeutic possibilities of para-aminobenxoic acid, Ann. 
Int.  Med. 30: 1188 (June) 1949. 
24. ZARAFONETIS, C. J. D.; CURTIS, A. C., AND SHAW, J. M.: Treatment of pemphigus with 
potassium para-aminobenzoate, Am.  J .  M .  Xc. 231: 30 (Jan.) 1956. 
25. ZARAFONETIS, C. J. D.: Lupus erythematosus and other collagen diseases. Presented 
a t  Meeting of The Michigan Academy of Practice (Symposium on Inflammation), 
Detroit, Mich., March 1, 1961. 
